News Article

Reimagining care: Eduardo Conrado on Ascension’s evolving strategy

Reimagining care: Eduardo Conrado on Ascension’s evolving strategy

At the heart of Ascension’s Vision is a deep commitment to the people we serve. Since stepping into the role of Chief Executive Officer in January 2026, Eduardo Conrado has continued to advance that Vision with intention – centering decisions on our Mission, empowering caregivers and clinicians, and accelerating a long-term strategy to expand access to more personalized, seamless care experiences.

Under Conrado’s leadership, Ascension is reimaging care around people, not buildings, shifting our footprint to better meet patient needs by strengthening primary care, expanding community partnerships, simplifying navigation, reducing friction, and prioritizing human connection. 

Read more about how Ascension is extending care beyond hospital walls to meet people where they are, with compassion, innovation, and adaptability.

Recent National News
How Ascension is investing in imaging to expand access, strengthen clinical capabilities, and support faster diagnoses
News Articles

How Ascension is investing in imaging to expand access, strengthen clinical capabilities, and support faster diagnoses

Ascension’s imaging strategy builds on a broad foundation of scale, clinical excellence, and community reach.
Expanding access to specialty care through digital innovation
News Articles

Expanding access to specialty care through digital innovation

As demand for specialty care continues to grow, Ascension is transforming how neurological and behavioral health care is delivered through a connected virtual care infrastructure.
Ascension Chief Pharmacy Officer Mike Wascovich Named to Becker's Hospital Review's
News Articles

Ascension Chief Pharmacy Officer Mike Wascovich Named to Becker's Hospital Review's "Chief Pharmacy Officers to Know" List

The annual list recognizes pharmacy leaders who are advancing medication safety, improving access to care, driving innovation, and helping health systems navigate an increasingly complex pharmaceutical landscape.